<div id="readability-page-1"><div><p>Health care stocks ended slightly lower with little fresh news to drive trading.</p><p>    Johnson &amp; Johnson said it closed its $3.05 billion acquisition of Halda Therapeutics, and that the deal is now expected to ding its adjusted earnings by 20 cents a share. Upon disclosing the deal last month, Johnson &amp; Johnson said it would reduce 2026 adjusted earnings by about 15 cents a share due to short-term financing and a charge related to equity awards for Halda employees. </p><p>   Write to Paulo Trevisani at paulo.trevisani@wsj.com </p><p>    (END) Dow Jones Newswires</p><p>12-29-25 1740ET</p></div></div>

强生

<p>医疗保健股票在轻微交易中小幅下跌。强生完成了对 Halda Therapeutics 的 30.5 亿美元收购，预计将对其调整后每股收益产生 20 美分的影响。此前，该公司预计由于对 Halda 员工的融资和股权奖励，2026 年的调整后收益将减少 15 美分</p>

医疗保健股票在清淡的交易中表现参差不齐——医疗保健综述